New clinical trial at Stony Brook Medicine could redefine treatment certain breast cancer patients

Stony Brook Medicine offers a clinical trial to test the safety and effectiveness of a tumor vaccine given to HER2-positive breast cancer patients with residual disease after preoperative chemotherapy.